KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Receivables (2016 - 2025)

Historic Receivables for Novavax (NVAX) over the last 15 years, with Q3 2025 value amounting to $39.4 million.

  • Novavax's Receivables fell 6382.3% to $39.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.4 million, marking a year-over-year decrease of 6382.3%. This contributed to the annual value of $121.4 million for FY2024, which is 6060.25% down from last year.
  • Per Novavax's latest filing, its Receivables stood at $39.4 million for Q3 2025, which was down 6382.3% from $231.7 million recorded in Q2 2025.
  • Novavax's 5-year Receivables high stood at $530.5 million for Q1 2022, and its period low was $29.3 million during Q1 2024.
  • For the 5-year period, Novavax's Receivables averaged around $188.1 million, with its median value being $124.8 million (2022).
  • Per our database at Business Quant, Novavax's Receivables surged by 57956.86% in 2021 and then crashed by 9091.27% in 2024.
  • Novavax's Receivables (Quarter) stood at $490.3 million in 2021, then crashed by 74.54% to $124.8 million in 2022, then skyrocketed by 152.96% to $315.7 million in 2023, then crashed by 61.56% to $121.4 million in 2024, then crashed by 67.56% to $39.4 million in 2025.
  • Its Receivables was $39.4 million in Q3 2025, compared to $231.7 million in Q2 2025 and $50.6 million in Q1 2025.